Mandakolathur R. Murali, M.B.,B.S., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Complement System Proteins | 3 | 2022 | 734 | 1.100 |
Why?
|
| Chest Pain | 3 | 2022 | 1091 | 1.000 |
Why?
|
| Dyskinesias | 1 | 2023 | 79 | 0.850 |
Why?
|
| Immunologic Tests | 2 | 2020 | 104 | 0.810 |
Why?
|
| Hereditary Angioedema Types I and II | 1 | 2022 | 10 | 0.800 |
Why?
|
| Complement C1 Inhibitor Protein | 1 | 2022 | 97 | 0.760 |
Why?
|
| Antibodies, Antinuclear | 5 | 2019 | 342 | 0.760 |
Why?
|
| Confusion | 1 | 2023 | 278 | 0.760 |
Why?
|
| Urticaria | 3 | 2022 | 150 | 0.750 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2019 | 427 | 0.630 |
Why?
|
| Immunoassay | 2 | 2020 | 744 | 0.550 |
Why?
|
| Echinococcus granulosus | 1 | 2015 | 11 | 0.500 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2015 | 82 | 0.490 |
Why?
|
| Echinococcosis, Hepatic | 1 | 2015 | 23 | 0.490 |
Why?
|
| Endarterectomy | 1 | 2015 | 196 | 0.480 |
Why?
|
| Anaphylaxis | 3 | 2022 | 757 | 0.460 |
Why?
|
| Rheumatoid Factor | 1 | 2014 | 184 | 0.460 |
Why?
|
| Complement Activation | 1 | 2015 | 445 | 0.440 |
Why?
|
| Serum Sickness | 1 | 2013 | 27 | 0.430 |
Why?
|
| Paraproteinemias | 4 | 2023 | 248 | 0.390 |
Why?
|
| Cold Temperature | 1 | 2015 | 785 | 0.380 |
Why?
|
| Cryoglobulins | 1 | 2011 | 58 | 0.380 |
Why?
|
| Autoimmune Diseases | 3 | 2019 | 2238 | 0.380 |
Why?
|
| Cryoglobulinemia | 1 | 2011 | 84 | 0.360 |
Why?
|
| Mastocytosis, Systemic | 1 | 2011 | 103 | 0.330 |
Why?
|
| Antibodies, Viral | 6 | 2021 | 3149 | 0.310 |
Why?
|
| Rheumatic Diseases | 1 | 2014 | 649 | 0.290 |
Why?
|
| Hepatitis B | 1 | 2013 | 704 | 0.290 |
Why?
|
| Autoantibodies | 1 | 2014 | 2115 | 0.260 |
Why?
|
| Diagnosis, Differential | 8 | 2022 | 12966 | 0.240 |
Why?
|
| Hyperesthesia | 1 | 2024 | 23 | 0.230 |
Why?
|
| Skin | 3 | 2017 | 4472 | 0.220 |
Why?
|
| Vasculitis | 1 | 2007 | 522 | 0.210 |
Why?
|
| Tuberculosis | 1 | 2015 | 2015 | 0.210 |
Why?
|
| Plasmacytoma | 1 | 2023 | 171 | 0.200 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2023 | 1171 | 0.200 |
Why?
|
| Pulmonary Embolism | 1 | 2015 | 2568 | 0.190 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2020 | 3798 | 0.190 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2020 | 745 | 0.180 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2017 | 974 | 0.180 |
Why?
|
| Bone Marrow | 1 | 2011 | 2909 | 0.180 |
Why?
|
| Cholesterol, HDL | 1 | 2006 | 1810 | 0.170 |
Why?
|
| Mobility Limitation | 1 | 2024 | 408 | 0.170 |
Why?
|
| Complement C3-C5 Convertases | 1 | 2019 | 30 | 0.170 |
Why?
|
| Drug Hypersensitivity | 2 | 2022 | 917 | 0.170 |
Why?
|
| Bone Marrow Cells | 1 | 2006 | 2409 | 0.160 |
Why?
|
| Liver | 1 | 2015 | 7512 | 0.160 |
Why?
|
| Immunoglobulin lambda-Chains | 2 | 2010 | 82 | 0.160 |
Why?
|
| Radiography, Abdominal | 1 | 2022 | 534 | 0.160 |
Why?
|
| Immunoglobulin kappa-Chains | 2 | 2010 | 169 | 0.150 |
Why?
|
| Psoriasis | 2 | 2017 | 944 | 0.150 |
Why?
|
| Edema | 1 | 2022 | 765 | 0.150 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2007 | 2152 | 0.140 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2006 | 1073 | 0.140 |
Why?
|
| Immunoglobulin M | 4 | 2020 | 1526 | 0.140 |
Why?
|
| Anemia | 1 | 2006 | 1504 | 0.140 |
Why?
|
| Hypotension | 2 | 2015 | 879 | 0.140 |
Why?
|
| Humans | 39 | 2024 | 760740 | 0.140 |
Why?
|
| Accidental Falls | 1 | 2024 | 1067 | 0.130 |
Why?
|
| Exanthema | 2 | 2013 | 503 | 0.130 |
Why?
|
| Dermatitis, Exfoliative | 1 | 2015 | 27 | 0.130 |
Why?
|
| Dermatitis | 1 | 2017 | 202 | 0.130 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2006 | 1639 | 0.120 |
Why?
|
| Prilocaine | 1 | 1995 | 21 | 0.120 |
Why?
|
| Multiple Myeloma | 2 | 2023 | 5144 | 0.120 |
Why?
|
| Fever | 3 | 2013 | 1618 | 0.120 |
Why?
|
| Medical Order Entry Systems | 1 | 2020 | 521 | 0.120 |
Why?
|
| B-Lymphocytes | 2 | 2010 | 4745 | 0.120 |
Why?
|
| Cost Savings | 1 | 2020 | 912 | 0.120 |
Why?
|
| Th2 Cells | 3 | 2016 | 1056 | 0.120 |
Why?
|
| Gene Deletion | 1 | 2022 | 2659 | 0.120 |
Why?
|
| Mixed Connective Tissue Disease | 1 | 2014 | 32 | 0.120 |
Why?
|
| Sensitivity and Specificity | 6 | 2021 | 14649 | 0.110 |
Why?
|
| Aspergillus flavus | 1 | 2013 | 14 | 0.110 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 1995 | 111 | 0.110 |
Why?
|
| Antitubercular Agents | 1 | 2022 | 1375 | 0.110 |
Why?
|
| Autoimmunity | 2 | 2011 | 1350 | 0.100 |
Why?
|
| Alveolitis, Extrinsic Allergic | 1 | 2013 | 63 | 0.100 |
Why?
|
| Thyroid Diseases | 1 | 2016 | 386 | 0.100 |
Why?
|
| Th17 Cells | 2 | 2016 | 793 | 0.100 |
Why?
|
| Heroin Dependence | 1 | 2013 | 172 | 0.100 |
Why?
|
| Kidney | 1 | 2007 | 7044 | 0.100 |
Why?
|
| Syncope | 1 | 2015 | 428 | 0.100 |
Why?
|
| Lidocaine | 1 | 1995 | 538 | 0.100 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 1213 | 0.100 |
Why?
|
| Aspergillus fumigatus | 1 | 2013 | 157 | 0.100 |
Why?
|
| Dermatan Sulfate | 1 | 2011 | 43 | 0.100 |
Why?
|
| Endocrine Gland Neoplasms | 1 | 2011 | 23 | 0.090 |
Why?
|
| Flushing | 1 | 2011 | 52 | 0.090 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 1936 | 0.090 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2010 | 91 | 0.090 |
Why?
|
| Acetylesterase | 1 | 2010 | 14 | 0.090 |
Why?
|
| Male | 15 | 2022 | 360402 | 0.090 |
Why?
|
| Radiography | 3 | 2013 | 6961 | 0.090 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2010 | 98 | 0.090 |
Why?
|
| Lymphatic Diseases | 2 | 2013 | 320 | 0.090 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2010 | 174 | 0.080 |
Why?
|
| Seroepidemiologic Studies | 2 | 2021 | 398 | 0.080 |
Why?
|
| Ribs | 1 | 2011 | 252 | 0.080 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2013 | 529 | 0.080 |
Why?
|
| Abdominal Pain | 1 | 2015 | 1070 | 0.080 |
Why?
|
| Dermatitis, Atopic | 1 | 2015 | 731 | 0.070 |
Why?
|
| Arthritis | 1 | 2013 | 680 | 0.070 |
Why?
|
| Paraproteins | 1 | 2006 | 38 | 0.070 |
Why?
|
| Autoantigens | 1 | 2011 | 888 | 0.070 |
Why?
|
| Thoracic Vertebrae | 1 | 2011 | 597 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 4340 | 0.070 |
Why?
|
| Blood Cell Count | 1 | 2006 | 397 | 0.060 |
Why?
|
| Gallbladder | 1 | 2007 | 308 | 0.060 |
Why?
|
| Middle Aged | 10 | 2022 | 220603 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2022 | 20556 | 0.060 |
Why?
|
| Adolescent | 3 | 2022 | 88247 | 0.060 |
Why?
|
| High-Throughput Screening Assays | 2 | 2021 | 933 | 0.060 |
Why?
|
| Immunoglobulin G | 3 | 2020 | 4533 | 0.060 |
Why?
|
| Fatal Outcome | 2 | 2007 | 1835 | 0.060 |
Why?
|
| Lupus Nephritis | 1 | 2007 | 317 | 0.060 |
Why?
|
| Models, Biological | 1 | 2019 | 9461 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 1 | 2014 | 1582 | 0.050 |
Why?
|
| Female | 13 | 2024 | 392203 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 3820 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3088 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3209 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2014 | 3461 | 0.050 |
Why?
|
| Knee | 1 | 2024 | 279 | 0.050 |
Why?
|
| Acute Disease | 1 | 2013 | 7236 | 0.050 |
Why?
|
| Adult | 10 | 2020 | 220995 | 0.050 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2023 | 285 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2010 | 1852 | 0.050 |
Why?
|
| Touch | 1 | 2024 | 310 | 0.050 |
Why?
|
| Lung | 2 | 2013 | 9999 | 0.050 |
Why?
|
| Receptors, IgG | 1 | 2005 | 558 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 5493 | 0.050 |
Why?
|
| Deglutition Disorders | 1 | 2007 | 627 | 0.050 |
Why?
|
| Disease Management | 1 | 2011 | 2506 | 0.040 |
Why?
|
| Foot | 1 | 2024 | 575 | 0.040 |
Why?
|
| Remote Sensing Technology | 1 | 2021 | 92 | 0.040 |
Why?
|
| Pathology, Molecular | 1 | 2023 | 329 | 0.040 |
Why?
|
| Blood Specimen Collection | 1 | 2021 | 238 | 0.040 |
Why?
|
| Dyslipidemias | 1 | 2006 | 868 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2020 | 816 | 0.040 |
Why?
|
| Hand | 1 | 2024 | 902 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2020 | 1057 | 0.040 |
Why?
|
| Toxocariasis | 1 | 1998 | 12 | 0.040 |
Why?
|
| Trichinellosis | 1 | 1998 | 27 | 0.040 |
Why?
|
| Echocardiography | 1 | 2011 | 4987 | 0.040 |
Why?
|
| Coronavirus | 1 | 2020 | 156 | 0.040 |
Why?
|
| Hypergammaglobulinemia | 1 | 1998 | 71 | 0.040 |
Why?
|
| Fingers | 1 | 2021 | 506 | 0.040 |
Why?
|
| Dermatomycoses | 1 | 1998 | 48 | 0.040 |
Why?
|
| Neoplasm, Residual | 1 | 2023 | 1008 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2011 | 6346 | 0.040 |
Why?
|
| Massachusetts | 2 | 2020 | 8835 | 0.040 |
Why?
|
| Capillaries | 1 | 2020 | 756 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2020 | 978 | 0.040 |
Why?
|
| Pemphigus | 1 | 1998 | 107 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2023 | 2509 | 0.030 |
Why?
|
| Efficiency | 1 | 2020 | 476 | 0.030 |
Why?
|
| Veins | 1 | 2020 | 767 | 0.030 |
Why?
|
| Aged | 4 | 2023 | 169092 | 0.030 |
Why?
|
| Aspergillosis | 1 | 1998 | 242 | 0.030 |
Why?
|
| Weight Loss | 1 | 2007 | 2682 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 2802 | 0.030 |
Why?
|
| Dyspnea | 2 | 2014 | 1347 | 0.030 |
Why?
|
| Ointments | 1 | 1995 | 58 | 0.030 |
Why?
|
| Patch Tests | 1 | 1995 | 57 | 0.030 |
Why?
|
| GATA3 Transcription Factor | 1 | 2015 | 154 | 0.030 |
Why?
|
| Ribonucleoprotein, U1 Small Nuclear | 1 | 2014 | 36 | 0.030 |
Why?
|
| Th1 Cells | 2 | 2015 | 1027 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 3688 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 7390 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2005 | 2722 | 0.030 |
Why?
|
| Raynaud Disease | 1 | 2014 | 79 | 0.030 |
Why?
|
| Eosinophilia | 1 | 1998 | 559 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2015 | 777 | 0.030 |
Why?
|
| Antigens, Differentiation | 1 | 2016 | 908 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2020 | 80583 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 2015 | 469 | 0.030 |
Why?
|
| Protein Binding | 3 | 2011 | 9345 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2023 | 5863 | 0.030 |
Why?
|
| Pericardial Effusion | 1 | 2014 | 247 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 1998 | 1502 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2017 | 1594 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2017 | 911 | 0.020 |
Why?
|
| Bence Jones Protein | 1 | 2010 | 18 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2011 | 283 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2020 | 6339 | 0.020 |
Why?
|
| Blood Protein Electrophoresis | 1 | 2010 | 65 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2015 | 871 | 0.020 |
Why?
|
| Myeloma Proteins | 1 | 2010 | 71 | 0.020 |
Why?
|
| Pandemics | 2 | 2021 | 8652 | 0.020 |
Why?
|
| Densitometry | 1 | 2010 | 151 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 3634 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2014 | 5965 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2024 | 58919 | 0.020 |
Why?
|
| Biocatalysis | 1 | 2010 | 170 | 0.020 |
Why?
|
| Half-Life | 1 | 2010 | 650 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5239 | 0.020 |
Why?
|
| Serum | 1 | 2010 | 208 | 0.020 |
Why?
|
| Cough | 1 | 2013 | 595 | 0.020 |
Why?
|
| Drug Combinations | 1 | 1995 | 2048 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 876 | 0.020 |
Why?
|
| Mast Cells | 1 | 2016 | 1392 | 0.020 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2014 | 851 | 0.020 |
Why?
|
| Phenotype | 2 | 2017 | 16572 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 17878 | 0.020 |
Why?
|
| Neuralgia | 1 | 1995 | 611 | 0.020 |
Why?
|
| Risk Factors | 1 | 2015 | 74128 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 20077 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2020 | 10072 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 1055 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2014 | 1302 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 12043 | 0.020 |
Why?
|
| Sample Size | 1 | 2010 | 838 | 0.020 |
Why?
|
| Hospitals | 1 | 2020 | 3879 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2007 | 11458 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10507 | 0.020 |
Why?
|
| Cytokines | 1 | 2020 | 7373 | 0.020 |
Why?
|
| Biopsy | 1 | 2017 | 6763 | 0.020 |
Why?
|
| Animals | 2 | 2015 | 168202 | 0.020 |
Why?
|
| Exons | 1 | 2010 | 2381 | 0.010 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2005 | 193 | 0.010 |
Why?
|
| Amyloidosis | 1 | 2010 | 815 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2011 | 5034 | 0.010 |
Why?
|
| Europe | 1 | 2010 | 3415 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 2005 | 509 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2013 | 1909 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 15829 | 0.010 |
Why?
|
| Prognosis | 1 | 2023 | 29601 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2005 | 23415 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 11069 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2005 | 575 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2016 | 9310 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 4739 | 0.010 |
Why?
|
| Alleles | 1 | 2010 | 6861 | 0.010 |
Why?
|
| Time Factors | 1 | 2020 | 39908 | 0.010 |
Why?
|
| Hematologic Neoplasms | 1 | 2010 | 1896 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 9586 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2010 | 9644 | 0.010 |
Why?
|
| Plasmapheresis | 1 | 1998 | 206 | 0.010 |
Why?
|
| Azathioprine | 1 | 1998 | 354 | 0.010 |
Why?
|
| Proteins | 1 | 2011 | 6030 | 0.010 |
Why?
|
| Cell Line | 1 | 2010 | 15577 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2010 | 3415 | 0.010 |
Why?
|
| Cyclosporine | 1 | 1998 | 776 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2010 | 3752 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 1998 | 850 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 64572 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 9171 | 0.010 |
Why?
|
| Prednisone | 1 | 1998 | 1562 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2005 | 3045 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2010 | 22153 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 1998 | 2218 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 15908 | 0.010 |
Why?
|
| Algorithms | 1 | 2010 | 14024 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 59191 | 0.000 |
Why?
|
| Immunosuppressive Agents | 1 | 1998 | 4172 | 0.000 |
Why?
|
| Child | 1 | 2013 | 80089 | 0.000 |
Why?
|
| Mice | 1 | 2010 | 81368 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1998 | 42193 | 0.000 |
Why?
|